Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged
Open Access
- 29 August 2024
- journal article
- review article
- Published by Springer Nature in EPMA Journal
- Vol. 15 (3) , 415-452
Abstract
Because of its rapid progression and frequently poor prognosis, stroke is the third major cause of death in Europe and the first one in China. Many independent studies demonstrated sufficient space for prevention interventions in the primary care of ischemic stroke defined as the most cost-effective protection of vulnerable subpopulations against health-to-disease transition. Although several studies identified molecular patterns specific for IS in body fluids, none of these approaches has yet been incorporated into IS treatment guidelines. The advantages and disadvantages of individual body fluids are thoroughly analyzed throughout the paper. For example, multiomics based on a minimally invasive approach utilizing blood and its components is recommended for real-time monitoring, due to the particularly high level of dynamics of the blood as a body system. On the other hand, tear fluid as a more stable system is recommended for a non-invasive and patient-friendly holistic approach appropriate for health risk assessment and innovative screening programs in cost-effective IS management. This article details aspects essential to promote the practical implementation of highlighted achievements in 3PM-guided IS management.Keywords
Funding Information
- Universitätsklinikum Bonn
This publication has 180 references indexed in Scilit:
- Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's diseaseAlzheimer's & Dementia, 2023
- MULTIOMIC PATTERNS IN BODY FLUIDS: TECHNOLOGICAL CHALLENGE WITH A GREAT POTENTIAL TO IMPLEMENT THE ADVANCED PARADIGM OF 3P MEDICINEMass Spectrometry Reviews, 2019
- Rare and Coding Region Genetic Variants Associated With Risk of Ischemic StrokeJAMA Neurology, 2015
- High Fidelity Between Saliva Proteomics and the Biologic State of Salivary Glands Defines Biomarker Signatures for Primary Sjögren's SyndromeArthritis & Rheumatology, 2014
- Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applicationsElectrophoresis, 2013
- Ischemic stroke is associated with the ABO locus: The EuroCLOT studyAnnals of Neurology, 2012
- Signatures of cardioembolic and large‐vessel ischemic strokeAnnals of Neurology, 2010
- Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic strokeAnnals of Neurology, 2008
- Evaluation of Serum S100B as a Surrogate Marker for Long-term Outcome and Infarct Volume in Acute Middle Cerebral Artery InfarctionArchives of Neurology, 2005
- Homocysteine and Risk of Ischemic Heart Disease and StrokeJAMA, 2002